Richard Ridinger

Richard Ridinger currently serves as the Chairman of the Supervisory Board and a Member of the Supervisory Board at Brenntag, and has held this position since June 2020. Additionally, Richard Ridinger is a Member of the Board of Directors at dsm-firmenich and has been since May 2023, and Richard holds the position of Chairman at Recipharm since March 2021. As a Member of the Novo Advisory Group for Novo Holdings since August 2019, Richard Ridinger also previously served as Chairman of Zentiva from June 2020 to May 2023, and as a Board Member at Firmenich from October 2016 to May 2023. Other board roles include being a Member of the Board of Directors at SHL Medical until March 2023, and a Member of the Board at Evolva Group and WIRB-Copernicus Group until May 2022 and April 2021, respectively. Richard Ridinger was the CEO of Lonza from May 2012 to April 2019. Academic credentials include a Diplomingenieur in Chemical Engineering from the Karlsruhe Institute of Technology, earned between 1979 and 1985.